Suppr超能文献

[医学检验与临床化学之间的桥梁]

[A go-between the laboratory medicine and clinical chemistry].

作者信息

Sakurabayashi Ikunosuke

机构信息

Department of Clinical Pathology, Omiya Medical Center, Jichi Medical School, Saitama 330-8503.

出版信息

Rinsho Byori. 2002 May;50(5):483-5.

Abstract

The Joint Annual Meeting of the Japanese Society of Laboratory Medicine and the Japanese Society of Clinical Chemistry is held in Yokohama at the first time in the history of both Societies. A chance of this time, we should consider the subjects to cooperate each Society. At first, standardization of the clinical tests at clinical laboratory field including clinical chemistry should be promoted by the both Societies. At second, EBLM(evidence based laboratory medicine) making the core of EBM (evidence based medicine) is very important tool practicing science based medicine by the reason of the getting out from experience-medicine. The hard effort which find out evidence on the clinical laboratory tests from enormous literature must be carried out on many clinical test items. In the Japanese Society of Laboratory Medicine, EBLM Committee was formed at last year and the work has been started. At third, if serum and other body fluids as well as tissues which are got from patients are used outside the purpose, ethics should be asked. Ethics Committee in both Society will make a guideline for the ethics for the handling the materials from patients including genetic subjects. At forth, clinical laboratory is said to be necessary the method of quality management(QM). The accreditation process is needed under unified national control survey, if we promote QM. At fifth, medical science rapidly advances at twenty-first century. Especially, there will be advanced at the fields of gene therapy, organ substitution, prevention and complete therapy of arteriosclerosis diseases and diabetes mellitus, terminal care, infectious diseases control and so on. The effective way of activating clinical laboratory is to related to those medical fields.

摘要

日本检验医学学会和日本临床化学学会的联合年会在两学会历史上首次于横滨举行。借此机会,我们应该考虑两学会合作的议题。首先,两学会应推动临床检验领域(包括临床化学)临床检验的标准化。其次,循证检验医学(EBLM)作为循证医学(EBM)的核心,是摆脱经验医学、践行循证医学的重要工具。必须针对众多临床检验项目,从海量文献中找出临床检验证据,这需要付出巨大努力。在日本检验医学学会,循证检验医学委员会已于去年成立并开展工作。第三,如果将从患者获取的血清及其他体液以及组织用于非既定目的,就需要遵循伦理规范。两学会的伦理委员会将制定关于处理包括基因相关样本在内的患者样本的伦理准则。第四,临床实验室据说需要质量管理(QM)方法。如果我们要推进质量管理,就需要在全国统一监管调查下进行认可程序。第五,医学在21世纪迅速发展。特别是在基因治疗、器官替代、动脉硬化疾病和糖尿病的预防与根治、临终关怀、传染病控制等领域将会取得进展。激活临床实验室的有效途径是与这些医学领域相关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验